Osteoporosis medications and oral health

June 2009
Journal of the American Dental Association (JADA);Jun2009, Vol. 140 Issue 6, p812
Academic Journal
The article focuses on osteoporosis medications and oral health of older people in the U.S. Osteoporosis which affects the quality of life of patients, is a condition in which bones become weak and prone to break due of various factors like diet, physical activity and medications like bisphosphonates which are known to reduce the risk of breaking bones. However, dentists found a condition called osteonecrosis of the jaw which they considered as a bisphosphonate-associated disease.


Related Articles

  • Osteonecrosis de los maxilares y bifosfonatos. Revisión. BONGIOVANNI, ISABEL R. // Revista de la Facultad de Odontología. Universidad Nacional de ;2012, Vol. 6 Issue 2, p43 

    The osteonecrosis of the jaw is the bone necrosis and exposure of the jaw bone and the maxilla, associated with the consumption of bisphosphonates. These are a family of drugs used in the treatment of bone disorders caused principally by malignant tumors (breast and prostate) and osteoporosis....

  • Osteonecrosis of the jaw after treatment with bisphosphonates. Landis, Basile Nicolas; Richter, Michel; Dojcinovic, Ivan; Hugentobler, Max // BMJ: British Medical Journal (International Edition);11/11/2006, Vol. 333 Issue 7576, p982 

    The author focuses on the fact that long term use of bisphosphonates increases the risk of avascular osteonecrosis of the jaw. Bisphosphonates are used in the treatment of metastatic bone malignancy, osteoporosis and Paget's disease. Since the effects of avascular osteonecrosis are irreversible,...

  • Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease. Bobba, Raja S.; Beattie, Karen; Parkinson, Bill; Kumbhare, Dinesh; Adachi, Jonathan D. // Drug Safety;2006, Vol. 29 Issue 12, p1133 

    Bisphosphonates are the primary pharmacological agents used for the management of osteoporosis and hypercalcaemia of malignant bone disease. The efficacy of these agents in these two conditions has been demonstrated in many well designed trials published over the past 2 decades. The variety of...

  • Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: A systematic review and meta-analysis. Lee, S. H.; Chang, S. S.; Lee, M.; Chan, R. C.; Lee, C. C. // International Journal of Prosthodontics;2014, Vol. 27 Issue 5, p468 

    An abstract of the article "Risk of Osteonecrosis in Patients Taking Bisphosphonates for Prevention of Osteoporosis: A Systematic Review and Meta-Analysis" by S. H. Lee, S. S. Chang, M. Lee, R. C. Chan, and C. C. Lee that appeared in a 2014 issue of the journal "Osteoporosis International" is...

  • Osteonecrosis of the jaw associated with antiresorptives: more evidence on the role of infection. Pazianas, Michael // IBMS BoneKEy;Nov2013, Vol. 10 Issue 11, p441 

    The author comments on the study conducted by S. Kalyan and colleagues which examines the role of infection in the initiation of osteonecrosis of the jaw (ONJ) associated with antiresorptives. He says that the significance of this study on the unaffected part of monocytes in patients treated...

  • Ostéonécrose des maxillaires : quand l'ancien traitement avec bisphosphonates est méconnu. Renoux, Marion; Folliguet, Marysette; Nguyen, Thông; Radoï, Loredana // Médecine Buccale Chirurgie Buccale;2014, Vol. 20 Issue 3, p177 

    Introduction: Older people have multiple morbidities and are polymedicated. The medicines are prescribed by several doctors who are unaware of each other, hence the increased risk of adverse effects. Observation: We report the case of an institutionalized 91-year-old female patient. Following a...

  • Alendronic acid.  // Reactions Weekly;2/28/2009, Issue 1241, p7 

    The article discusses research being done on the link between oral bisphosphonate use and the prevalence of osteonecrosis of the jaw. It references a study published in the January 2009 issue of "Journal of the American Dental Association." The patients in the study developed jaw osteonecrosis...

  • Alendronic acid.  // Reactions Weekly;8/8/2009, Issue 1264, p5 

    The article presents a case study of a 71-year-old woman who, while receiving oral alendronic acid, developed osteonecrosis of the jaw. The patient presented with a swelling on the lower-right facial area and had osteoporosis. After six months of bisphosphonate holiday with conservative...

  • Pathophysiology of Osteonecrosis of the Jaw in Patients Treated with Bisphosphonate. Badel, Tomislav; Pavičin, Ivana Savić; Carek, Andreja Jelinić; Rošin-Grget, Kata; Grbeša, Ðurdica // Collegium Antropologicum;Jun2013, Vol. 37 Issue 2, p645 

    Apart from the well-known mechanism of bisphosphonates' cellular effect, embryonic development and the specific features of alveolar bone homeostasis have been discussed. The unique ethiopathogenic mechanism which relates osteo-necrosis of the jaw and bisphosphonates treatment has not been...


Read the Article


Sign out of this library

Other Topics